Displaying items by tag: Division of Pulmonary, Allergy and Critical Medicine

Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
Three UAB investigators have received innovative research grants for lung diseases from the National Institutes of Health.
UAB’s Mark Dransfield has been elected to the American Society for Clinical Investigation, an honor society for physician-scientists who have made significant contributions to better understanding of human disease.
UAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.
Page 4 of 9